Corindus Vascular Robotics Inc (CVRS)

Sector:
HEALTH CARE
Industry:
HEALTH CARE SERVICES
SIC:
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
CEO:
Mark J. Toland
Employees:
90
309 WAVERLEY OAKS ROAD, SUITE 105, WALTHAM, MA 02452
508-653-3335

• *** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

Corindus Vascular Robotics, Inc. designs, manufactures and sells precision vascular robotic-assisted systems for use in interventional vascular procedures. Its FDA cleared CorPath System offers precision and accuracy to stent placement in percutaneous coronary intervention procedures. The company was founded by Tal Wenderow on May 4, 2011 and is headquartered in Waltham, MA.

Data derived from most recent annual or quarterly report
Market Cap 891.106 Million Shares Outstanding208.69 Million Avg 30-day Volume 1.402 Million
P/E Ratio0.0 Dividend Yield0.0 EPS-0.11
Price to Revenue40.6934 Debt to Equity0.8051 EBITDA-34.253 Million
Price to Book Value0.0 Operating Margin-224.7737 Enterprise Value627.122 Million
Current Ratio3.006 EPS Growth0.174 Quick Ratio2.786
1 Yr BETA 1.56 52-week High/Low 0.0 / Profit Margin-232.043
Operating Cash Flow Growth17.7253 Free Cash Flow to Firm (FCFF) TTM -22.806 Million Free Cash Flow to Equity (FCFE) TTM-24.634 Million
Altman Z-Score5.6271
View SEC Filings from CVRS instead.

View recent insider trading info

Corindus Vascular Robotics Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding CVRS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CVRS

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2019-10-31 by CANNON LOUIS A
  • 4: filed on 2019-10-31 by TOBIN JAMES R
  • 4: filed on 2019-10-31 by HARRINGTON NATHAN R
  • 4: filed on 2019-10-31 by ROGERS CAMPBELL
  • 4: filed on 2019-10-31 by GOLD JEFFREY
  • 4: filed on 2019-10-31 by LONG DAVID W
  • 4: filed on 2019-10-31 by TEANY DOUGLAS
  • 4: filed on 2019-10-31 by TOLAND MARK J
  • 4: filed on 2019-10-31 by BRAUNSTEIN DOUGLAS L
  • 4: filed on 2019-10-31 by KONINKLIJKE PHILIPS NV

    • Events (8k)

  • 8-K: filed on 2019-10-29:
    Item 1.02: Termination of a Material Definitive Agreement
    Item 2.01: Completion of Acquisition or Disposition of Assets
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
    Item 3.03: Material Modifications to Rights of Security Holders
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 9.01: Financial Statements and Exhibits
    Item 5.01: Changes in Control of Registrant
  • 8-K: filed on 2019-10-25:
    Item 5.07: Submission of Matters to a Vote of Security Holders
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2019-10-18:
    Item 8.01: Other Events
  • 8-K: filed on 2019-08-08:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2019-08-08:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2019-05-08:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2019-05-07:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2019-03-12:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2019-02-27:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 3.02: Unregistered Sales of Equity Securities
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2019-01-04:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    GOLD JEFFREY

    • Director
    		 No longer subject to file 2019-10-29 0

    TOBIN JAMES R

    • Director
    		 No longer subject to file 2019-10-29 0

    HEALTHCOR MANAGEMENT, L.P.

    HEALTHCOR PARTNERS FUND II, L.P.

    HEALTHCOR PARTNERS II, L.P.

    HEALTHCOR PARTNERS GP, LLC

    COHEN ARTHUR BRUCE

    HEALEY JOSEPH PATRICK

    • 10% Owner
    		 No longer subject to file 2019-10-29 0

    HEALTHCOR MANAGEMENT, L.P.

    HEALTHCOR ASSOCIATES, LLC

    HEALTHCOR HYBRID OFFSHORE MASTER FUND, L.P.

    HEALTHCOR HYBRID OFFSHORE GP, LLC

    HEALTHCOR GROUP, LLC

    HEALTHCOR PARTNERS MANAGEMENT LP

    HEALTHCOR PARTNERS MANAGEMENT GP, LLC

    HEALTHCOR PARTNERS FUND LP

    HEALTHCOR PARTNERS LP

    • 10% Owner
    		 No longer subject to file 2019-10-29 0

    BRAUNSTEIN DOUGLAS L

    • Director
    		 No longer subject to file 2019-10-29 0

    LIGHTCAP JEFFREY C

    • Director
    • 10% Owner
    		 No longer subject to file 2019-10-29 0

    ROGERS CAMPBELL

    • Director
    		 No longer subject to file 2019-10-29 0

    LONG DAVID W CFO/SR VP/SEC./TREASURER

    • Officer
    		 No longer subject to file 2019-10-29 0

    HUDSON EXECUTIVE CAPITAL LP

    HEC MANAGEMENT GP LLC

    • 10% Owner
    		 No longer subject to file 2019-10-29 0

    TOLAND MARK J PRESIDENT AND CEO

    • Officer
    • Director
    		 No longer subject to file 2019-10-29 0

    CANNON LOUIS A

    • Director
    		 No longer subject to file 2019-10-29 0

    HARRINGTON NATHAN R

    • Director
    		 No longer subject to file 2019-10-29 0

    TEANY DOUGLAS CHIEF OPERATING OFFICER

    • Officer
    		 No longer subject to file 2019-10-29 0

    LEMASTER STEPHEN JEFFREY CHIEF COMMERCIAL OFFICER

    • Officer
    		 0 2018-02-02 0

    BAKEWELL JOHN K

    • Director
    		 0 2017-12-15 0

    KONINKLIJKE PHILIPS NV

    • 10% Owner
    		 26,358,858 2017-10-11 0

    WHITE DAVID RICHARD

    • Director
    		 0 2016-09-27 0

    BACHRACH HILLEL

    • Director
    		 0 2016-09-27 0

    HANDLER DAVID M CEO/PRESIDENT

    • Officer
    • Director
    		 0 2015-05-28 0

    WINKELS GERARD

    • Director
    		 0 2015-05-28 0

    MASHAAL MICHAEL Y

    • Director
    		 0 2015-05-21 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    WhaleWisdom Logo

    Elevate your investments